UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Details {2}
Sales, net	$ 8,722	$ 9,710
Cost of goods sold	3,440	4,172
Gross profit	5,282	5,538
Operating expense
Selling, general and administrative	2,563	2,231
Research & development	154	154
Total operating expenses	2,717	2,385
Operating income	2,565	3,153
Other income	617	705
Income before provision for income taxes	3,182	3,858
Provision for income taxes	578	817
Net income	$ 2,604	$ 3,041
Earnings per share, basic	$ 0.82	$ 0.92
Earnings per common share (diluted)	$ 0.82	$ 0.92
Shares outstanding (basic)	3,185	3,310
Shares outstanding (diluted)	3,185	3,310
Foreign currency translation net of taxes of $0 in all periods	$ (503)	$ 718
Total comprehensive income	$ 2,101	$ 3,759